Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Vladimir Coric
ResearcherPublications, citations & collaboration network
Vladimir Coric is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 166 works, 7,958 citations, an h-index of 42 and an i10-index of 78.
166
Works
7,958
Citations
42
h-index
78
i10-index
IDs:OpenAlex
How has Vladimir Coric's publication output changed over time?
ScholarIQpublication output · 2005–2022
Output grew0% over the shown period — from 1 works in 2005 to 1 in 2022.
1
1
1
2
1
1
2
1
1
200520062007201220132015201920202022
What are the most-cited papers on Vladimir Coric?
ScholarIQmost cited works
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder
Michael H. Bloch, Angeli Landeros‐Weisenberger, Ben Kelmendi, Vladimir Coric, Michael B. Bracken, James F. Leckman
S71149355. 2006625 Citations
Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine
Richard B. Lipton, Robert Croop, Elyse Stock, David Stock, Beth Morris, Marianne Frost, Gene M. Dubowchik, Charles M. Conway, Vladimir Coric, Peter J. Goadsby
New England Journal of Medicine. 2019403 CitationsOPEN ACCESS
Genome-wide association study of obsessive-compulsive disorder
S. Evelyn Stewart, Dongmei Yu, Jeremiah M. Scharf, Benjamin M. Neale, Jesen Fagerness, Carol A. Mathews, Paul Arnold, Patrick Evans, Eric R. Gamazon, Lisa Osiecki, Lauren M. McGrath, Stephen A. Haddad, Jacquelyn Crane, Dianne M. Hezel, C Illman, C Mayerfeld, Anuar Konkashbaev, Chunyu Liu, Anna Pluzhnikov, А. А. Тихомиров, Christopher K. Edlund, Scott L. Rauch, R. Moessner, Peter Falkai, W. Maier, Stephan Ruhrmann, HJ Grabe, Leonhard Lennertz, Michael Wagner, Laura Bellodi, Maria Cristina Cavallini, Margaret A. Richter, Edwin H. Cook, James L. Kennedy, David Rosenberg, Dan J. Stein, Sian Hemmings, Christine Löchner, Amin Azzam, Denise A. Chavira, Eduardo Fournier, Helena Garrido, Brooke Sheppard, Paula Umaña, Dennis L. Murphy, Jens R. Wendland, Jeremy Veenstra‐VanderWeele, Damiaan Denys, Rianne M. Blom, Dieter Deforce, Filip Van Nieuwerburgh, H.G.M. Westenberg, Susanne Walitza, Karin Egberts, Tobias Renner, Eurı́pedes Constantino Miguel, Carolina Cappi, Ana Gabriela Hounie, Maria Conceição do Rosário, Aline S. Sampaio, Homero Vallada, Humberto Nicolini, Nuria Lanzagorta, Beatríz Camarena, Richard Delorme, Marion Leboyer, Carlos N. Pato, Michele T. Pato, Emanuel Voyiaziakis, Peter Heutink, Daniëlle C. Cath, Daniëlle Posthuma, Johannes H. Smit, Jack Samuels, O. Joseph Bienvenu, Bernadette Cullen, Abby J. Fyer, Marco A. Grados, Benjamin D. Greenberg, James T. McCracken, Mark A. Riddle, Ying Wang, Vladimir Coric, James F. Leckman, Michael H. Bloch, Christopher Pittenger, Valsamma Eapen, Donald W. Black, Roel A. Ophoff, E Strengman, Daniele Cusi, Maurizio Turiel, Francesca Frau, Fabìo Macciardi, J. Raphael Gibbs, M R Cookson, Andrew Singleton, Sampath Arepalli, M R Cookson, Allissa Dillman
S71149355. 2012398 CitationsOPEN ACCESS
Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial
Robert Croop, Peter J. Goadsby, David Stock, Charles M. Conway, Micaela Forshaw, Elyse Stock, Vladimir Coric, Richard B. Lipton
The Lancet. 2019398 Citations
Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
Vladimir Coric, Christopher H. van Dyck, Stephen Salloway, Niels Andreasen, Mark Brody, Ralph Richter, Hilkka Soininen, Stephen Thein, Thomas Shiovitz, Gary D. Pilcher, Susan Colby, Linda Rollin, Randy Dockens, Chahin Pachaï, Erik Portelius, Ulf Andréasson, Kaj Blennow, Holly Soares, Charles F. Albright, Howard Feldman, Robert Berman
Archives of Neurology. 2012372 Citations
Related on ScholarIQ
Biohaven Pharmaceuticals (United States)
Institution
A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder
Paper
Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine
Paper
Genome-wide association study of obsessive-compulsive disorder
Paper
Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial
Paper
Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
Paper